Gyre Therapeutics (GYRE) Earnings Date & Reports

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GYRE is expected to report earnings to fall 95.24% to -5 cents per share on November 13

Gyre Therapeutics GYRE Stock Earnings Reports

Q3'23

Est.

$-0.05

Q2'23

Missed

by $0.98

Q1'23

Beat

by $0.22

Q4'22

Missed

by $18.94

Q3'22

Missed

by $2.30

The last earnings report on August 03 showed earnings per share of -104 cents, missing the estimate of -7 cents. With 103.33K shares outstanding, the current market capitalization sits at 831.28M.

View a ticker or compare two or three

Compare

GYRE